medicine

Our medicine

Olanib

Olaparib INN 50 mg

Osimert

Osimertinib INN 80 mg

Ibruxen

Ibrutinib INN 140mg

Niranib

Niraparib Tosylate Monohydrate equivalent to Niraparib 100 Mg

Ponaxen 45

Ponatinib Hydrochloride INN equivalent to Ponatinib 45 mg

Lenvaxen 4

Lenvatinib Mesylate INN equivalent to Lenvatinib 4 mg

Laronib 100

Larotrectinib INN 100 mg

Caboxen 20

Cabozantinib INN 20 mg

Ventoxen

Venetoclax INN 100 mg

Palboxen

Palbociclib INN 125 mg

Tucaxen 150

Tucatinib 1NN 150 mg

Prostaxen

Apalutamide INN 60 mg

Sotoxen

Sotorasib INN 120 mg

Selcaxen

Selpercatinib INN 40 mg

Trifluxen

Triﬂuridine BP 15 mg /Tipiracil INN 6.14 mg

Ribotix

Ribociclib

Ribociclib 200 mg (Ribotix) is a CDK4/6 inhibitor that is indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer.

Talk to us

Have any questions? We are always open to talk about your business, new projects, creative opportunities and how we can help you.